Department of Drug Metabolism and Pharmacokinetics, Research Laboratory for Development, Shionogi & Co., Ltd., 3-1-1, Futaba-cho, Toyonaka, Osaka, 561-0825, Japan,
EJNMMI Res. 2014 Dec;4(1):57. doi: 10.1186/s13550-014-0057-z. Epub 2014 Oct 9.
Hepatic mitochondrial dysfunction has been implicated in pathological conditions leading to non-alcoholic steatohepatitis (NASH). Technetium-99 m-2-methoxyisobutyl-isonitrile ((99m)Tc-MIBI), a lipophilic cationic myocardial perfusion agent, is retained in the mitochondria depending on membrane potential. The aim of this study was to investigate the feasibility of (99m)Tc-MIBI for evaluating the hepatic mitochondrial dysfunction induced by methionine-choline-deficient (MCD) diet in mice.
Male C57Black6J/jcl mice were fed a MCD diet for up to 4 weeks. SPECT scan (N =6) with (99m)Tc-MIBI was performed at 2 and 4 weeks after MCD diet. Mice were imaged with small-animal SPECT/CT under isoflurane anesthesia. Radioactivity concentrations of the liver were measured, and the time of maximum (T max) and the elimination half-life (T 1/2) were evaluated. After SPECT scan, liver histopathology was analyzed to evaluate steatosis and inflammation. Non-alcoholic fatty liver disease (NAFLD) activity score was obtained from the histological score of hepatic steatosis and inflammation. Blood biochemistry and hepatic ATP content were also measured (N =5 to 6).
Plasma alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels were significantly elevated at 2 and 4 weeks after MCD diet. A decrease in hepatic ATP content was also observed in MCD-fed mice. (99m)Tc-MIBI SPECT imaging clearly showed the decrease of hepatic (99m)Tc-MIBI retention in MCD-fed mice compared to control mice. T 1/2 after (99m)Tc-MIBI injection was significantly decreased in the liver of MCD-fed mice (control, MCD 2 weeks, and MCD 4 weeks, T 1/2 = 57.6, 37.6, and 19.8 min, respectively), although no change in T max was observed in MCD-fed mice. SPECT data and histological score showed that the negative correlation (r = -0.74, p <0.05) between T 1/2 and NAFLD activity score was significant.
Hepatic (99m)Tc-MIBI elimination was increased with increase in NAFLD activity score (NAS) in mice fed MCD diet for 2 and 4 weeks. These results suggest that (99m)Tc-MIBI SPECT imaging might be useful for detecting hepatic mitochondrial dysfunction induced by steatosis and inflammation such as NAFLD or NASH.
肝线粒体功能障碍与导致非酒精性脂肪性肝炎(NASH)的病理状况有关。锝-99m-2-甲氧基异丁基异腈((99m)Tc-MIBI),一种亲脂性阳离子心肌灌注剂,根据膜电位保留在线粒体中。本研究旨在探讨(99m)Tc-MIBI 评估 MCD 饮食诱导的小鼠肝线粒体功能障碍的可行性。
雄性 C57Black6J/jcl 小鼠接受 MCD 饮食长达 4 周。用(99m)Tc-MIBI 进行 SPECT 扫描(N=6),在 MCD 饮食后 2 周和 4 周进行。在异氟烷麻醉下,对小鼠进行小动物 SPECT/CT 成像。测量肝脏的放射性浓度,并评估最大时间(T max)和消除半衰期(T 1/2)。SPECT 扫描后,分析肝组织病理学以评估脂肪变性和炎症。从肝脂肪变性和炎症的组织学评分中获得非酒精性脂肪性肝病(NAFLD)活动评分。还测量了血液生化和肝 ATP 含量(N=5 至 6)。
MCD 饮食后 2 周和 4 周,血浆丙氨酸氨基转移酶(ALT)和天冬氨酸氨基转移酶(AST)水平显著升高。MCD 喂养的小鼠肝 ATP 含量也降低。(99m)Tc-MIBI SPECT 成像清楚地显示,与对照组相比,MCD 喂养的小鼠肝(99m)Tc-MIBI 保留减少。MCD 喂养的小鼠肝脏(99m)Tc-MIBI 注射后的 T 1/2 明显缩短(对照组、MCD 2 周和 MCD 4 周,T 1/2=57.6、37.6 和 19.8min),尽管 MCD 喂养的小鼠 T max 无变化。SPECT 数据和组织学评分显示,MCD 饮食喂养 2 周和 4 周后,T 1/2 与 NAFLD 活动评分(NAS)之间呈负相关(r=-0.74,p<0.05)。
MCD 饮食喂养 2 周和 4 周后,肝(99m)Tc-MIBI 消除增加与 NAFLD 活性评分(NAS)增加有关。这些结果表明,(99m)Tc-MIBI SPECT 成像可能有助于检测由脂肪变性和炎症引起的肝线粒体功能障碍,如非酒精性脂肪性肝病或 NASH。